These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33845361)

  • 1. Response to: COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?
    Toss A
    ESMO Open; 2021 Jun; 6(3):100109. PubMed ID: 33845361
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?
    Tomasik B; Braun M
    ESMO Open; 2021 Jun; 6(3):100108. PubMed ID: 33862335
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic.
    Crivellaro P; Tafur M; George R; Muradali D
    Eur Radiol; 2022 Jan; 32(1):613-620. PubMed ID: 34143286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of the COVID-19 Pandemic on Breast Imaging.
    Freer PE
    Radiol Clin North Am; 2021 Jan; 59(1):1-11. PubMed ID: 33222992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors.
    Miller MM; Meneveau MO; Rochman CM; Schroen AT; Lattimore CM; Gaspard PA; Cubbage RS; Showalter SL
    Breast Cancer Res Treat; 2021 Aug; 189(1):237-246. PubMed ID: 34032985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on a population-based breast cancer screening program.
    Peng SM; Yang KC; Chan WP; Wang YW; Lin LJ; Yen AM; Smith RA; Chen TH
    Cancer; 2020 Dec; 126(24):5202-5205. PubMed ID: 32914864
    [No Abstract]   [Full Text] [Related]  

  • 7. Selecting Patients for Mammographic Evaluation Based on Breast Cancer Risk During the COVID-19 Pandemic.
    Friedewald SM; Gupta D
    JAMA Netw Open; 2021 Mar; 4(3):e212546. PubMed ID: 33764418
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing the Risk of Delayed Breast Cancer Screening Versus COVID-19 Vaccination Associated Axillary Lymphadenopathy.
    Garver K
    Acad Radiol; 2021 Sep; 28(9):1198-1199. PubMed ID: 34400078
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating Trends in Screening Mammography Volumes at a Tertiary Academic Institution During the COVID-19 Pandemic.
    Ambinder EB; Carson KA; Nguyen DL; Cha E; Peshtani A; Myers KS; Oluyemi ET
    J Am Coll Radiol; 2024 Jul; 21(7):1067-1071. PubMed ID: 38378103
    [No Abstract]   [Full Text] [Related]  

  • 10. Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
    Vanni G; Pellicciaro M; Materazzo M; Bruno V; Oldani C; Pistolese CA; Buonomo C; Caspi J; Gualtieri P; Chiaravalloti A; Palombi L; Piccione E; Buonomo OC
    In Vivo; 2020; 34(5):3047-3053. PubMed ID: 32871851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disproportionate Sociodemographic Effects of Suspended Breast Cancer Screening During the COVID-19 Pandemic.
    Narvacan K; Patlas MN
    Can Assoc Radiol J; 2024 May; 75(2):218-219. PubMed ID: 38063155
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan.
    Tsai HY; Chang YL; Shen CT; Chung WS; Tsai HJ; Chen FM
    Breast; 2020 Dec; 54():52-55. PubMed ID: 32919172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collateral damages of the Covid-19 pandemic in breast cancer screening].
    Villaseñor-Navarro Y; Sollozo-Dupont I
    Salud Publica Mex; 2021 Jun; 63(4):461. PubMed ID: 35077083
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic.
    Bakouny Z; Paciotti M; Schmidt AL; Lipsitz SR; Choueiri TK; Trinh QD
    JAMA Oncol; 2021 Mar; 7(3):458-460. PubMed ID: 33443549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Breast Imaging for Timely Diagnosis of Disease.
    Bicchierai G; Di Naro F; De Benedetto D; Cozzi D; Pradella S; Miele V; Nori J
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34063854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on the volume of mammography examinations in Southern Taiwan.
    Chou CP; Pan HB; Yang TL; Chiang CL; Huang JS; Tsai MY
    Breast J; 2021 Jan; 27(1):89-91. PubMed ID: 32815587
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.
    Fujii MH; Herschorn SD; Sowden M; Hotaling EL; Vacek PM; Weaver DL; Sprague BL
    AJR Am J Roentgenol; 2019 Mar; 212(3):706-711. PubMed ID: 30673339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hindsight is 2020: Understanding the Impact of the COVID-19 Pandemic on a Provincial Population-Based Breast Screening Program.
    Bentley H; Woods R; Mar C; Tang T; Raveinthiranathan N; Kellow Z; Yong-Hing CJ
    Can Assoc Radiol J; 2022 Aug; 73(3):589-591. PubMed ID: 34758655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.